Elsevier

Genomics

Volume 13, Issue 4, August 1992, Pages 931-934
Genomics

Assignment of the human glycogen debrancher gene to chromosome 1p21

https://doi.org/10.1016/0888-7543(92)90003-BGet rights and content

Abstract

Glycogen debranching enzyme is a monomeric protein containing two independent catalytic activities of glycantransferase and glucosidase that are both required for glycogen degradation. Its deficiency causes type III glycogen storage disease. A majority of the patients with this disease have deficient enzyme activity in both liver and muscle (type IIIa) but ∼15% of them lack enzyme activity only in the liver (type IIIb); however, the enzyme is a monomer and appears to be identical in all the tissues. The cDNA coding for the complete human muscle debranching enzyme has recently been isolated. Using the cDNA clones, the debrancher gene was localized to human chromosome 1 by somatic cell hybrid analysis. Regional assignment to chromosome band 1p21 was determined by in situ hybridization. Mapping of the debrancher gene to a single chromosome site is consistent with our hypotheses that a single gene encodes both liver and muscle debrancher protein.

References (15)

There are more references available in the full text version of this article.

Cited by (60)

  • Developmental and Inherited Liver Disease

    2023, MacSween's Pathology of the Liver, Eighth Edition
  • A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III

    2021, Molecular Genetics and Metabolism Reports
    Citation Excerpt :

    GSD III (OMIM 232400) is caused by a deficiency of the glycogen debrancher enzyme (GDE; OMIM 610860), an enzyme with two independent catalytic activities: amylo-1,6-glucosidase (EC 3.2.1.33) and 4-alpha-glucanotransferase (EC 2.4.1.25) [1]. Together with glycogen phosphorylase, GDE degrades glycogen to release glucose and glucose-1-phosphate for use as a source of energy [1]. A deficiency of GDE leads to an accumulation of abnormally structured glycogen, called limit dextrin, which is characterized by short outer chains.

  • Abnormalities of Carbohydrate Metabolism and the Liver

    2020, Pediatric Gastrointestinal and Liver Disease, Sixth Edition
  • Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis

    2018, Pediatric Clinics of North America
    Citation Excerpt :

    Type IIIa accounts for 85% of people with GSD III, and involves the liver, heart, and muscles; type IIIb only affects the liver.44 Both GSD IIIa and IIIb are caused by mutations in the AGL gene.45 GSD III has a wide clinical spectrum.

  • Developmental and Inherited Liver Disease

    2018, MacSween's Pathology of the Liver
View all citing articles on Scopus
View full text